Page 3 - Jonathan Bagger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail IMAGE: The facade of the Advanced Rare Isotope Laboratory (ARIEL) on TRIUMF's campus in Vancouver, B.C., Canada view more  Credit: Stu Shepherd Scientists and engineers at TRIUMF, Canada's particle accelerator centre, announced a major milestone for TRIUMF's Advanced Rare Isotope Laboratory (ARIEL), maneuvering for the first time an isotope beam through the ARIEL-based CANREB facility and on to an experiment. The achievement marks a watershed moment for the laboratory's future-facing science program, which leverages TRIUMF's unique accelerator infrastructure to drive impact ...

 E-Mail VANCOUVER, British Columbia, December 16, 2020 - TRIUMF, Canada's particle accelerator centre, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Under the agreement, Fusion will provide a financial investment enabling TRIUMF to upgrade its actinium-225 production infrastructure, and in return will receive preferred access to actinium-225, a rare medical isotope that shows great promise in new, cutting-edge ca...

TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a Cancer-Fighting Medical Isotope VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) -- TRIUMF, Canada’s particle accelerator centre, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Under the agreement, Fusion will provide a financial investment enabling TRIUMF to upgrade its actinium-225 production infrastruct...